Nashville Post
Front Page

Research

From R&D to revenue

How Vanderbilt is turning greater-good research into cash [From our print edition featured in Monday's City Paper]

Monetizing the mission

From genetic markers to spinach's solar power, a look at some promising studies being conducted at Vanderbilt [From our print edition featured in Monday's City Paper]

Manufacturer relocating division HQ to town

Unit coming here from Southern California -- UPDATED with details on jobs and real estate search

Health care information venture lands Philly deal

VC partner of research consortium looks to locals to facilitate communication

Vanderbilt joins cancer consortium

University one of 10 centers tasked with developing new cancer treatments

'It is an exciting and busy time for us'

Sam Lynch has BioMimetic on a steady growth path. Next up: Two important product launches [From our print edition featured in Monday's City Paper]

Sarah Cannon Research Institute inks two deals

Institute expands both oncology and non-oncology focused research networks

Fischer resigns from Battelle

Former Sundquist aide leaves R&D organization less than three months after major promotion

Taking stock: BioMimetic gets FDA clearance on study

Also: Clarcor CFO sells big and Tennessee Commerce back in NASDAQ's good graces

1   2    Next »

Now Playing Nashville